Exploratory clinical study of eribulin followed by taxane for metastatic breast cancer patients
Not Applicable
Recruiting
- Conditions
- Metastatic breast cancer
- Registration Number
- JPRN-UMIN000027527
- Lead Sponsor
- Yamaguchi University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)HER2+ 2)Concurrent active infections 3)The presence of brain metastasis requiring treatment 4)Sever complications Current uncontorolled CHF History of myocardial infractionwithin 6 months of randomization Cirrhosis of the liver Interstitial pneumonaitis Hemorrhagic Diathesis 5)Patients with synchronous double cancer 6)Pregnant or nursing women or who suspected pregnant 7)The patients combination has been chemotherapy,immunotherapy,hormone therapy,radiation therapy and surgical treatment 8)Assessed by the investigator to be unable or unwilling to comply with the requirements of the protocol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method